Osaic Holdings’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $22.6K | Buy |
389
+70
| +22% | +$3.23K | ﹤0.01% | 5772 |
|
|
2025
Q4 | $14.3K | Sell |
319
-1,055
| -77% | -$44.3K | ﹤0.01% | 6095 |
|
|
2025
Q3 | $55K | Buy |
1,374
+149
| +12% | +$5.25K | ﹤0.01% | 5251 |
|
|
2025
Q2 | $40.2K | Buy |
1,225
+1,034
| +541% | +$33.7K | ﹤0.01% | 5210 |
|
|
2025
Q1 | $6.41K | Sell |
191
-272
| -59% | -$10.3K | ﹤0.01% | 6042 |
|
|
2024
Q4 | $18.1K | Buy |
463
+4
| +0.9% | +$165 | ﹤0.01% | 5415 |
|
|
2024
Q3 | $18.1K | Sell |
459
-78
| -15% | -$3.15K | ﹤0.01% | 5448 |
|
|
2024
Q2 | $20.9K | Sell |
537
-293
| -35% | -$11.7K | ﹤0.01% | 5316 |
|
|
2024
Q1 | $35.7K | Sell |
830
-1,835
| -69% | -$84.4K | ﹤0.01% | 4972 |
|
|
2023
Q4 | $123K | Sell |
2,665
-1,222
| -31% | -$43.2K | ﹤0.01% | 4280 |
|
|
2023
Q3 | $133K | Buy |
3,887
+1,196
| +44% | +$44.7K | ﹤0.01% | 4293 |
|
|
2023
Q2 | $104K | Buy |
2,691
+2,009
| +295% | +$79.9K | ﹤0.01% | 4409 |
|
|
2023
Q1 | $24.4K | Buy |
682
+6
| +0.9% | +$222 | ﹤0.01% | 5456 |
|
|
2022
Q4 | $27K | Buy |
676
+85
| +14% | +$3.1K | ﹤0.01% | 5372 |
|
|
2022
Q3 | $22K | Buy |
591
+328
| +125% | +$11.8K | ﹤0.01% | 5526 |
|
|
2022
Q2 | $8K | Buy |
263
+163
| +163% | +$4.93K | ﹤0.01% | 6257 |
|
|
2022
Q1 | $3K | Hold |
100
| – | – | ﹤0.01% | 6785 |
|
|
2021
Q4 | $3K | Sell |
100
-275
| -73% | -$8.22K | ﹤0.01% | 6922 |
|
|
2021
Q3 | $6K | Hold |
375
| – | – | ﹤0.01% | 6477 |
|
|
2021
Q2 | $7K | Sell |
375
-375
| -50% | -$6.91K | ﹤0.01% | 6266 |
|
|
2021
Q1 | $13K | Hold |
750
| – | – | ﹤0.01% | 5749 |
|
|
2020
Q4 | $12K | Hold |
750
| – | – | ﹤0.01% | 5449 |
|
|
2020
Q3 | $8K | Hold |
750
| – | – | ﹤0.01% | 5404 |
|
|
2020
Q2 | $9K | Hold |
750
| – | – | ﹤0.01% | 5243 |
|
|
2020
Q1 | $9K | Buy |
+750
| New | +$10.7K | ﹤0.01% | 5084 |
|
Other funds holding XENE
ACA
DCM
PCH
